DrugId:  1
1. Name:  Strontium chloride
2. Groups:  Approved
3. Description:  Strontium chloride (SrCl2) is a salt of strontium and chloride. SrCl2 is useful in reducing tooth sensitivity by forming a barrier over microscopic tubules in the dentin containing nerve endings that have become exposed by gum recession.
4. Indication:  Not Available
DrugId:  2
1. Name:  2-Hydroxymethyl-Pyrrolidine-3,4-Diol
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  3
1. Name:  (2Z,3E)-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE 3-{O-[(3R)-3,4-DIHYDROXYBUTYL]OXIME}
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  4
1. Name:  ANILINOMETHYL GLUCO-PHENYLIMIDAZOLE
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  5
1. Name:  Sodium fluoride
2. Groups:  Approved
3. Description:  Sodium fluoride is an inorganic chemical compound. A colorless solid, it is a source of the fluoride ion in diverse applications. Sodium fluoride is less expensive and less hygroscopic than the related salt potassium fluoride.
4. Indication:  To prevent cavities. 
DrugId:  6
1. Name:  (3R)-8-(dioxidosulfanyl)-3-methyl-1,2,3,4-tetrahydroquinoline
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  7
1. Name:  (2r,3r,4s,5r)-2-Acetamido-3,4-Dihydroxy-5-Hydroxymethyl-Piperidinium
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  8
1. Name:  2,5-Dideoxy-2,5-Imino-D-Glucitol
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  9
1. Name:  (R)-tacrine(10)-hupyridone
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  10
1. Name:  (2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  11
1. Name:  (1S,2S,3R,6R)-4-(hydroxymethyl)-6-(octylamino)cyclohex-4-ene-1,2,3-triol
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  12
1. Name:  N-[(1R,2R,3E)-2-hydroxy-1-(hydroxymethyl)heptadec-3-en-1-yl]acetamide
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  13
1. Name:  PIPERIDINE-2-CARBOXYLIC ACID TERT-BUTYLAMIDE
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  14
1. Name:  N-(pyridin-3-ylmethyl)aniline
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  15
1. Name:  1-N-Acetyl-Beta-D-Glucosamine
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  16
1. Name:  1-Deoxy-6-O-Phosphono-1-[(Phosphonomethyl)Amino]-L-Threo-Hexitol
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  17
1. Name:  1-(Isopropylamino)-3-(1-Naphthyloxy)-2-Propanol
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  18
1. Name:  N-benzyl-4-[(2R)-pyrrolidin-2-ylmethoxy]aniline
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  19
1. Name:  N-Allyl-Aniline
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  20
1. Name:  N~3~-BENZYLPYRIDINE-2,3-DIAMINE
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  21
1. Name:  Afegostat
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  22
1. Name:  (S)-tacrine(10)-hupyridone
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  23
1. Name:  (1S,2R,3S,4R,5S)-8-AZABICYCLO[3.2.1]OCTANE-1,2,3,4-TETROL
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  24
1. Name:  SC45647
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  25
1. Name:  MK-1496
2. Groups:  Investigational
3. Description:  MK-1496 has been used in trials studying the treatment of Neoplasms and Malignant.
4. Indication:  Not Available
